[1]Geisler A,Fechner H.MicroRNA-regulated viral vectors for gene therapy[J].World J Exp Med,2016,6(2):37-54.
[2]Wagemaker G.Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders[J].Hum Gene Ther,2014,25(10):862-865.
[3]Herrera-Carrillo E,Berkhout B.Bone marrow gene therapy for HIV/AIDS[J].Viruses,2015,7(7):3910-3936.
[4]Craig AJ,Housley GD.Evaluation of gene therapy as an intervention strategy to treat brain injury from stroke[J].Front Mol Neurosci,2016,9:34.
[5]Meng F,Chen C,Wan H,et al.Advances of lentiviral vectors[J].Chin J Lung Cancer,2014,17(12):870-876.
[6]Tarapore RS,Yang Y,Katz JP.Restoring KLF5 in esophageal squamous cell cancer cells activates the JNK pathway leading to apoptosis and reduced cell survival[J].Neoplasia,2013,15(5):472-480.
[7]Sun X,Liu G,Wang Z.Over-expression of VEGF165 in the adipose tissue-derived stem cells via the lentiviral vector[J].Chinese Medical Journal,2011,124(19):3093-3097.
[8]Shearer RF,Saunders DN.Experimental design for stable genetic manipulation in mammalian cell lines:lentivirus and alternatives[J].Genes Cells,2015,20(1):1-10.
[9]Merienne N,Déglon N.Gene silencing approaches for the treatment of Huntington's disease[J].Med Sci(Paris),2015,31(2):159-167.
[10]de Andrade Pereira B,Fraefel C.Novel immunotherapeutic approaches in targeting dendritic cells with virus vectors[J].Discov Med,2015,20(109):111-119.
[11]Chira S,Jackson CS.Progresses towards safe and efficient gene therapy vectors[J].Oncotarget,2015,6(31):30675-30703.
[12]Xue R,Gu J,Du S.Lentivirus-mediated RNA interference targeting the ObR gene in human breast cancer MCF-7cells in a nude mouse xenograft model[J].Chinese Medical Journal,2012,125(9):1563-1570.
[13]Gao N,Zhang X,Jiang R,et al.Lentivirus-mediated RNA interference and over-expression of CDK2AP1 cDNA regulate CDK2AP1 expression in human lung cancer A549 cells[J].Chem Res Chinese Universities,2011,27(3):445-449.
[14]Pfeifer A,Hofmann A.Lentiviral transgenesis[J].Methods Mol Biol,2009,530(3):391-405.
[15]Siming X,Weiyi F.Zhen L.Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin[J].Transl Med,2008,6(1):55-63.
[16]Kock N,Kasmieh R,Weissleder R.el al.Tumor theraphy mediated by lentiviral expression of shBcl-2 and S-TRAIL[J].Neoplasia,2007,9(5):435-442.
[17] Akhtar J,Wang Z,Zhang ZP,et al.Lentiviral-mediated RNA interference targeting stathmin 1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo[J].Journal of Translational Medicine,2013,11(1):212.
[18]Zhao B,Yang C,Yang S,et al.Construction of conditional lentivirus-mediated shRNA vector targeting the human Mirk gene and identification of RNAi efficiency in rhabdomyosarcoma RD cells[J].International Journal of Oncology,2013,43(9):1253-1259.
[19]Guang Y,Chen H,Jun C.Lentivirus-mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion[J].World Journal of Gastroenterology,2009,15(30):3757-3766.
[20]Li XM,You YQ,Liu GZ,et al.Preparation and determination of the green fluorescent protein (GFP) transgenic mouse induced by lentivirus vector[J].Medical Journal of Chinese People's Liberation Army,2011,36(9):964-966.[李秀梅,尤玉琴,刘光泽,等.慢病毒介导的绿色荧光蛋白转基因小鼠的制备及鉴定[J].解放军医学杂志,2011,36(9):964-966.]
[21]Tan G,Niu J,Shi Y,et al.NF-B-dependent microRNA-125b up-regulation promotes cell survival by targeting p38 upon ultraviolet radiation[J].Biol Chem,2012,287(39):33036-33047.
[22]Schambach A,Zychlinski D.Biosafety features of lentiviral vectors[J].Hum Gene Ther,2013,24(2):132-142.
[23]Demeulemeester J,De Rijck J.Retroviral integration:Site matters:Mechanisms and consequences of retroviral integration site selection[J].Bioessays,2015,37(11):1202-1214.
[24]Wang CX,Torbett BE.Role of the mammalian target of rapamycin pathway in lentiviral vector transduction of hematopoietic stem cells[J].Curr Opin Hematol,2015,22(4):302-308.
[25]Deal CE,Balazs AB.Vectored antibody gene delivery for the prevention or treatment of HIV infection[J].Curr Opin HIV AIDS,2015,10(3):190-197.